Annals of hematology

Keyphrases

Publications

volume 102, number 4, 2023

Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology 102 (4) (2023)
Shanshan Li, Yujuan Gao, Fei Li, Yu Zheng, Yanhua Su
Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia. Annals of hematology 102 (4) (2023)
Rong Zhang, Yabin Liu, Huan Song, Yun Tan, Wen Jin, Huiying Zhao, Xiaowu Liu, Jing Li, Gangfeng Wang, Li Chen, Yingmin Liang, Kankan Wang
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia. Annals of hematology 102 (4) (2023)
Tongtong Zhang, Haixia Zhou, Mingzhu Xu, Chongsheng Qian, Aining Sun, Depei Wu, Shengli Xue
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia. Annals of hematology 102 (4) (2023)

volume 102, number 6, 2023

Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Kimberley Doucette, Allison O Taylor, Bryan Chan, Xiaoyang Ma, Jaeil Ahn, David H Vesole, Catherine Lai
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis. Annals of hematology 102 (6) (2023)
Taku Kikuchi, Nobuhiro Tsukada, Moe Nomura, Yuki Kasuya, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment. Annals of hematology 102 (6) (2023)
Mitsuhiro Shimada, Shojiro Inano, Toshiyuki Kitano
T-cell lymphoma associated with dupilumab. Annals of hematology 102 (6) (2023)
Kimberley Doucette, Allison O Taylor, Bryan Chan, Xiaoyang Ma, Jaeil Ahn, David H Vesole, Catherine Lai
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis. Annals of hematology 102 (6) (2023)
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Toshihiro Okuya, Tatsu Shimoyama
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of hematology 102 (6) (2023)
Mitsuhiro Shimada, Shojiro Inano, Toshiyuki Kitano
T-cell lymphoma associated with dupilumab. Annals of hematology 102 (6) (2023)
Inge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M A Blijlevens, Willem M Smit, Bjorn T Gjertsen, Tobias Gedde-Dahl, Berit Markevärn, Malika M A Koppes, Peter E Westerweel, Henrik Hjorth-Hansen, Jeroen J W M Janssen
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of hematology 102 (6) (2023)
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Toshihiro Okuya, Tatsu Shimoyama
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of hematology 102 (6) (2023)
Franz Ewendt, Marvin Schmitt, Alexander Kluttig, Julia Kühn, Frank Hirche, Frank B Kraus, Beatrice Ludwig-Kraus, Rafael Mikolajczyk, Wim Wätjen, Paul-Christian Bürkner, Michael Föller, Gabriele I Stangl
Association between vitamin D status and eryptosis-results from the German National Cohort Study. Annals of hematology 102 (6) (2023)
Kimberley Doucette, Allison O Taylor, Bryan Chan, Xiaoyang Ma, Jaeil Ahn, David H Vesole, Catherine Lai
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis. Annals of hematology 102 (6) (2023)
Inge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M A Blijlevens, Willem M Smit, Bjorn T Gjertsen, Tobias Gedde-Dahl, Berit Markevärn, Malika M A Koppes, Peter E Westerweel, Henrik Hjorth-Hansen, Jeroen J W M Janssen
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of hematology 102 (6) (2023)
Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Lidan Zhu, Jia Liu, Shichun Gao, Ting Chen, Huanfeng Liu, Han Yao, Yuqing Liu, Yimei Feng, Lu Zhao, Yuxia Li, Lei Gao, Xi Zhang
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Annals of hematology 102 (6) (2023)
Mitsuhiro Shimada, Shojiro Inano, Toshiyuki Kitano
T-cell lymphoma associated with dupilumab. Annals of hematology 102 (6) (2023)
Franz Ewendt, Marvin Schmitt, Alexander Kluttig, Julia Kühn, Frank Hirche, Frank B Kraus, Beatrice Ludwig-Kraus, Rafael Mikolajczyk, Wim Wätjen, Paul-Christian Bürkner, Michael Föller, Gabriele I Stangl
Association between vitamin D status and eryptosis-results from the German National Cohort Study. Annals of hematology 102 (6) (2023)
Inge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M A Blijlevens, Willem M Smit, Bjorn T Gjertsen, Tobias Gedde-Dahl, Berit Markevärn, Malika M A Koppes, Peter E Westerweel, Henrik Hjorth-Hansen, Jeroen J W M Janssen
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of hematology 102 (6) (2023)
Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Lidan Zhu, Jia Liu, Shichun Gao, Ting Chen, Huanfeng Liu, Han Yao, Yuqing Liu, Yimei Feng, Lu Zhao, Yuxia Li, Lei Gao, Xi Zhang
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Annals of hematology 102 (6) (2023)
Ignacio Gómez-Centurión, Reyes Maria Martin Rojas, Rebeca Bailén, Cristina Muñoz, Santiago Sabell, Gillen Oarbeascoa, Paula Fernández-Caldas, Diego Carbonell, Jorge Gayoso, Carolina Martínez-Laperche, Ismael Buño, Javier Anguita, José Luis Díez-Martin, Mi Kwon
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide. Annals of hematology 102 (6) (2023)
Franz Ewendt, Marvin Schmitt, Alexander Kluttig, Julia Kühn, Frank Hirche, Frank B Kraus, Beatrice Ludwig-Kraus, Rafael Mikolajczyk, Wim Wätjen, Paul-Christian Bürkner, Michael Föller, Gabriele I Stangl
Association between vitamin D status and eryptosis-results from the German National Cohort Study. Annals of hematology 102 (6) (2023)
Muhammad Hossein Ashoub, Amirreza Naseri, Parisa Mohammadi, Masoud Mohammadi
Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis. Annals of hematology 102 (6) (2023)
Taku Kikuchi, Nobuhiro Tsukada, Moe Nomura, Yuki Kasuya, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment. Annals of hematology 102 (6) (2023)
Franz Ewendt, Marvin Schmitt, Alexander Kluttig, Julia Kühn, Frank Hirche, Frank B Kraus, Beatrice Ludwig-Kraus, Rafael Mikolajczyk, Wim Wätjen, Paul-Christian Bürkner, Michael Föller, Gabriele I Stangl
Association between vitamin D status and eryptosis-results from the German National Cohort Study. Annals of hematology 102 (6) (2023)
Lu Wang, Peiyan Kong, Cheng Zhang, Li Gao, Lidan Zhu, Jia Liu, Shichun Gao, Ting Chen, Huanfeng Liu, Han Yao, Yuqing Liu, Yimei Feng, Lu Zhao, Yuxia Li, Lei Gao, Xi Zhang
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Annals of hematology 102 (6) (2023)
Süreyya Yiğit Kaya, Sebnem Bektas, Abdullah Emre Askin, Berrin Balık Aydın, Yaşa Gül Mutlu, Omur Gokmen Sevindik
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Annals of hematology 102 (6) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Reham Alghandour, Doaa H Sakr, Yasmin Shaaban
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. Annals of hematology 102 (6) (2023)
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Toshihiro Okuya, Tatsu Shimoyama
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of hematology 102 (6) (2023)
Muhammad Hossein Ashoub, Amirreza Naseri, Parisa Mohammadi, Masoud Mohammadi
Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis. Annals of hematology 102 (6) (2023)
Süreyya Yiğit Kaya, Sebnem Bektas, Abdullah Emre Askin, Berrin Balık Aydın, Yaşa Gül Mutlu, Omur Gokmen Sevindik
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Annals of hematology 102 (6) (2023)
Jeesun Yoon, Ki Hwan Kim, Jung Sun Kim, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Youngil Koh, Tae Min Kim, Inho Kim, Sung-Soo Yoon, Dae Seog Heo, Hyunkyung Park, Jin Hyun Park
Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute. Annals of hematology 102 (6) (2023)
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Alexandra Jungova, Petr Pavlicek, Lenka Pospisilova, Frantisek Sedlak, Jan Straub, Tomas Pika, Zdenka Knechtova, Anna Fidrichova, Ivanna Boichuk, Sabina Sevcikova, Vladimir Maisnar, Roman Hajek, Ludek Pour
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis. Annals of hematology 102 (6) (2023)
Reham Alghandour, Doaa H Sakr, Yasmin Shaaban
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. Annals of hematology 102 (6) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Reham Alghandour, Doaa H Sakr, Yasmin Shaaban
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. Annals of hematology 102 (6) (2023)
Taku Kikuchi, Nobuhiro Tsukada, Moe Nomura, Yuki Kasuya, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment. Annals of hematology 102 (6) (2023)
Muhammad Hossein Ashoub, Amirreza Naseri, Parisa Mohammadi, Masoud Mohammadi
Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis. Annals of hematology 102 (6) (2023)
Süreyya Yiğit Kaya, Sebnem Bektas, Abdullah Emre Askin, Berrin Balık Aydın, Yaşa Gül Mutlu, Omur Gokmen Sevindik
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Annals of hematology 102 (6) (2023)
Jeesun Yoon, Ki Hwan Kim, Jung Sun Kim, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Youngil Koh, Tae Min Kim, Inho Kim, Sung-Soo Yoon, Dae Seog Heo, Hyunkyung Park, Jin Hyun Park
Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute. Annals of hematology 102 (6) (2023)
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Alexandra Jungova, Petr Pavlicek, Lenka Pospisilova, Frantisek Sedlak, Jan Straub, Tomas Pika, Zdenka Knechtova, Anna Fidrichova, Ivanna Boichuk, Sabina Sevcikova, Vladimir Maisnar, Roman Hajek, Ludek Pour
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis. Annals of hematology 102 (6) (2023)
Satoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, Sachiko Seo, Naoyuki Uchida, Miyakoshi Shigesaburo, Nobuaki Nakano, Kazuya Ishiwata, Yasufumi Uehara, Tetsuya Eto, Ken Takase, Toshiro Kawakita, Masatsugu Tanaka, Masashi Sawa, Yuta Katayama, Yuichiro Nawa, Onizuka Makoto, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, Masamitsu Yanada
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of hematology 102 (6) (2023)
Ignacio Gómez-Centurión, Reyes Maria Martin Rojas, Rebeca Bailén, Cristina Muñoz, Santiago Sabell, Gillen Oarbeascoa, Paula Fernández-Caldas, Diego Carbonell, Jorge Gayoso, Carolina Martínez-Laperche, Ismael Buño, Javier Anguita, José Luis Díez-Martin, Mi Kwon
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide. Annals of hematology 102 (6) (2023)
Jeesun Yoon, Ki Hwan Kim, Jung Sun Kim, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Youngil Koh, Tae Min Kim, Inho Kim, Sung-Soo Yoon, Dae Seog Heo, Hyunkyung Park, Jin Hyun Park
Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute. Annals of hematology 102 (6) (2023)
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Alexandra Jungova, Petr Pavlicek, Lenka Pospisilova, Frantisek Sedlak, Jan Straub, Tomas Pika, Zdenka Knechtova, Anna Fidrichova, Ivanna Boichuk, Sabina Sevcikova, Vladimir Maisnar, Roman Hajek, Ludek Pour
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis. Annals of hematology 102 (6) (2023)
Ignacio Gómez-Centurión, Reyes Maria Martin Rojas, Rebeca Bailén, Cristina Muñoz, Santiago Sabell, Gillen Oarbeascoa, Paula Fernández-Caldas, Diego Carbonell, Jorge Gayoso, Carolina Martínez-Laperche, Ismael Buño, Javier Anguita, José Luis Díez-Martin, Mi Kwon
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide. Annals of hematology 102 (6) (2023)